221 related articles for article (PubMed ID: 15513349)
1. Colorectal cancer screening.
Ederer F; Church T; Mandel J
Scand J Gastroenterol; 2004 Oct; 39(10):1031-2; author reply 1029-30. PubMed ID: 15513349
[No Abstract] [Full Text] [Related]
2. [Arguments against implementing a population-based screening programme for colorectal cancer].
Bonneux L
Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1777. PubMed ID: 18754310
[TBL] [Abstract][Full Text] [Related]
3. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer (Br J Surg 2008; 95: 1029-1036).
Corder AP; Iqbal M; Devaraj S
Br J Surg; 2008 Nov; 95(11):1428-9; author reply 1429. PubMed ID: 18844282
[No Abstract] [Full Text] [Related]
4. Colorectal cancer screening and surveillance: the present and the future.
Rex DK
Rev Gastroenterol Disord; 2001; 1(1):18-31. PubMed ID: 12120116
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, effectiveness and cost-effectiveness of endoscopic screening methods.
Brenner H
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S20-2. PubMed ID: 18368634
[TBL] [Abstract][Full Text] [Related]
6. Screening for colorectal cancer: which test can we afford?
Lansdorp-Vogelaar I; van Ballegooijen M; Kuipers EJ
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S38-40. PubMed ID: 18368641
[No Abstract] [Full Text] [Related]
7. [Screening for colorectal cancer: what is the most effective strategy?].
Merzenich H; Giersiepen K; Kieschke J; Zeeb H
Gesundheitswesen; 2005 Nov; 67(11):803-8. PubMed ID: 16308813
[TBL] [Abstract][Full Text] [Related]
8. Importance of colorectal cancer screening.
Hurst JS
Am Fam Physician; 2003 Mar; 67(6):1188. PubMed ID: 12674445
[No Abstract] [Full Text] [Related]
9. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer screening in Scotland.
Steele RJ
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S33-4. PubMed ID: 18368639
[No Abstract] [Full Text] [Related]
11. [Colorectal cancer screening should be evaluated in Swedish studies].
Blom J
Lakartidningen; 2008 Sep 17-23; 105(38):2564-7. PubMed ID: 18846858
[No Abstract] [Full Text] [Related]
12. Virtual colonoscopy: what is its role in cancer screening?
Ahluwalia JS; Miser WF; Bova JG
J Fam Pract; 2007 Mar; 56(3):186-91. PubMed ID: 17343807
[No Abstract] [Full Text] [Related]
13. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds.
Kronborg O; Jørgensen OD; Fenger C; Rasmussen M
Scand J Gastroenterol; 2004 Sep; 39(9):846-51. PubMed ID: 15513382
[TBL] [Abstract][Full Text] [Related]
14. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
[TBL] [Abstract][Full Text] [Related]
15. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.
Malila N; Oivanen T; Hakama M
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S25-8. PubMed ID: 18368636
[TBL] [Abstract][Full Text] [Related]
16. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
17. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer.
Lindholm E; Brevinge H; Haglind E
Br J Surg; 2008 Aug; 95(8):1029-36. PubMed ID: 18563785
[TBL] [Abstract][Full Text] [Related]
18. [Detection and prevention of colorectal cancer].
Moubayed H; Popescu R; Aellen S; Givel JC; Michetti P; Dorta G
Rev Med Suisse Romande; 2002 Sep; 122(9):413-6. PubMed ID: 12422468
[No Abstract] [Full Text] [Related]
19. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
[TBL] [Abstract][Full Text] [Related]
20. From screening criteria to colorectal cancer screening: what can New Zealand learn from other countries?
Shaw C; Cunningham R; Sarfati D
N Z Med J; 2008 Aug; 121(1279):84-95. PubMed ID: 18709051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
